Executive Summary
The Federal Quality Commission (EQK) has adopted comprehensive recommendations to prevent conflicts of interest in Swiss hospitals following an investigation into incidents in cardiac surgery at the University Hospital Zurich (2016–2020). Cantons should henceforth tie the admission of hospitals to hospital lists to the obligation for complete disclosure of conflicts of interest by medical personnel. Hospital management and supervisory bodies must also enforce compliance with ethical standards in research projects and experimental treatments and investigate violations promptly.
Persons
- Federal Quality Commission (EQK) (Authority Commission of the EDI)
Topics
- Medical ethics and patient protection
- Conflicts of interest in health institutions
- Regulation of research projects and experimental treatments
- Quality control in the Swiss healthcare system
Clarus Lead
The recommendations address a systemic deficit: material self-interests of physicians endanger patients when control mechanisms are lacking. By linking hospital list admission to disclosure obligations, the EQK creates a direct incentive for cantons to enforce transparency. The Zurich case demonstrates that informal self-regulation is insufficient – the recommendations now call for binding institutional structures (ethics committees, documentation, monitoring) as a prerequisite for continuing research and experimental treatments.
Detailed Summary
The EQK identifies two central areas of action in its report. First, the disclosure of conflicts of interest: senior medical, nursing, and therapeutic staff must consistently and regularly disclose their conflicts of interest. This applies especially to decision-makers in treatment and research contexts. The cantons are given the authority to anchor this disclosure obligation as a condition for hospital listing – a lever for comprehensive implementation.
Second, the governance of research and experimental treatments: hospital management must ensure that all projects are approved by competent ethics committees or review boards, that a careful benefit-risk assessment is conducted, that patients are fully informed, and that their participation is voluntary. Complete documentation and continuous monitoring of study progress – including treatment and healing outcomes – are mandatory. Violations of ethical standards or legal requirements (in particular the Human Research Act) must be investigated immediately and addressed with appropriate protective measures.
The EQK justifies these measures with the necessity to enable progress in medicine and therapy without sacrificing patient safety. This requires responsible and critical behavior from hospital management as well as active oversight by licensing bodies.
Key Statements
- Conflicts of interest of hospital professionals must be systematically disclosed and updated; cantons can enforce this as a listing condition.
- Research projects and experimental treatments require binding ethical governance: ethics committee approval, benefit-risk assessment, informed consent, documentation, and monitoring.
- Violations of ethical or legal standards warrant immediate investigation and protective measures.
Critical Questions
Enforceability: How will cantons be monitored to ensure they actually anchor the disclosure obligation as a listing condition? What sanctions apply for non-compliance?
Data Protection vs. Transparency: Which conflicts of interest must be disclosed (e.g., stock ownership, consulting fees, family relationships)? Where is the line between legitimate transparency and data protection?
Ethics Committee Capacity: Are ethics committees in smaller cantons and hospitals adequately equipped and independent to properly evaluate all research projects?
Retroactive Application: Do the new standards apply to ongoing or already commenced research projects, or only to future ones?
Monitoring Resources: Who monitors compliance with documentation and monitoring obligations? Are supervisory bodies adequately staffed and methodologically equipped for this?
Conflicts of Interest in Research: How are conflicts of interest handled within the ethics committees themselves to avoid circular evaluations?
Source Directory
Primary Source: Federal Quality Commission (EQK) – Recommendations on Conflicts of Interest and Ethical Standards – https://www.bag.admin.ch/de/eqk-empfehlungen
Further Information:
- Federal Quality Commission (EQK) – https://www.eqk.admin.ch
- Federal Health Insurance Act (KVG, SR 832.10)
Verification status: ✓ 23.07.2026
This text was created with the support of an AI model. Editorial responsibility: clarus.news | Fact-checking: 23.07.2026